Hancocks ,i am a bit surprised at your debate about aquisitions--surely you must know it is happening alot.
Now,whether anyone wants PEB, is a different debate.
But just in terms of acquisitions...
http://www.thepharmaletter.com/listi...diseases?tagid[]=48
It does seem at times that supporters spend alot of time researching the product(fair enough) but far less time researching the outside markets. OK they have 12 sales staff and things have been slowed up because of the affordable care act--thats a start.
I realize its not an easy thing to research but it should keep the lid on getting to carried away with predictions (actually you have been pretty level headed in that area--i should direct that to another poster)
I can see how some posters can rub you the wrong way,(maybe Im guilty of that also)but surely you must see how the ''daily advertising'' also detracts more than it helps.
On a completely different note--How would you feel about an acquisition? More money in holders pocket in exchange for being gobbled up by a big player and the resulting loss of identity.(this is not a for or against PEBs present course--just an interesting concept given the level of interest in this thread.